started · updated
Biotechnology and medical device markets projected to grow through 2034
The global biotechnology and medical technology sectors are experiencing significant growth driven by advancements in precision medicine, genomics, and targeted therapeutics.
Key market segments include:
• Genotyping Assays: Projected to grow from USD 19.4 billion in 2024 to USD 37.1 billion by 2029, fueled by DNA sequencing advancements and the rising prevalence of genetic disorders.
• Bioconjugation: Expected to reach USD 10.86 billion by 2029, supported by the development of antibody-drug conjugates (ADCs) and increased pharmaceutical R&D.
• C-arms: The market is forecasted to grow from USD 2.22 billion in 2026 to USD 3.19 billion by 2034, driven by rising disease prevalence and healthcare innovation.
• Peptide Synthesis: Anticipated to expand from USD 0.98 billion in 2026 to USD 1.54 billion by 2031, spurred by the demand for metabolic peptides like GLP-1 and oncology therapies.